- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Sierra Oncology, Inc.
Total 1050 results
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis (PMF) | Post-essential Thrombocythemia Myelofibrosis (Post-ET MF) | Post-polycythemia Vera (Post-PV)United States, Canada, France, Italy, Germany, Spain, Israel, United Kingdom
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis | Post-Polycythemia Vera | Post-Essential Thrombocythemia MyelofibrosisUnited States, Canada
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States, Canada, Australia
-
Sierra Oncology, Inc.TerminatedRelapsed Metastatic KRAS-Mutated Non-Small Cell Lung CancerUnited States
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States, France, Germany, Spain, Israel, Bulgaria, Romania, Japan, Taiwan, Korea, Republic of, Australia, Belgium, Canada, Netherlands, Singapore, Poland, Hungary, Denmark, Sweden, United Kingdom, Czechia, Austria
-
Sierra Oncology, Inc.CompletedMelanoma | Lymphoma | Cancer | Prostate CancerUnited States
-
Sierra Oncology, Inc.TerminatedPolycythemia Vera | Essential ThrombocythemiaUnited States, France, Germany, Canada, Australia
-
Sierra Oncology, Inc.TerminatedEGFR Mutated EGFR TKI Naive Metastatic NSCLCUnited States
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States, Canada, Australia
-
Sierra Oncology, Inc.TerminatedRelapsed/Refractory Metastatic Pancreatic Ductal AdenocarcinomaUnited States
-
Sierra Oncology LLC - a GSK companyCompletedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisKorea, Republic of, Canada, Hungary, Israel, Spain, United States, Australia, Taiwan, Singapore, Germany, Italy, France, Belgium, New Zealand, Austria, United Kingdom, Denmark, Bulgaria, Poland, Czechia, Romania, Sweden
-
Sierra Oncology LLC - a GSK companyTerminatedRichter's TransformationUnited States
-
Sierra Oncology LLC - a GSK companyCompletedPrimary Myelofibrosis (PMF) | Post-polycythemia Vera (Post-PV) Myelofibrosis | Postessential Thrombocythemia (Post-ET) MyelofibrosisUnited States, Canada
-
Sierra Oncology LLC - a GSK companyCompletedAdvanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)United Kingdom
-
Sierra Oncology LLC - a GSK companyTerminatedMetastatic Pancreatic Ductal AdenocarcinomaUnited States
-
Sierra Oncology LLC - a GSK companyCompletedLymphoma, Non-Hodgkin'sUnited States
-
Sierra Oncology LLC - a GSK companyCompletedLymphoma, Diffuse Large B-CellUnited States, Puerto Rico
-
Sierra Oncology LLC - a GSK companyCompletedAdvanced Solid TumorsSpain, United Kingdom
-
Sierra Oncology LLC - a GSK companyCompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States, France, Canada, Germany, Australia
-
Sientra, Inc.Active, not recruitingBreast Augmentation | Breast Reconstruction | Breast RevisionUnited States
-
Sientra, Inc.Active, not recruitingBreast Fat Grafting RetentionUnited States
-
Sientra, Inc.CompletedBreast Augmentation | Breast Reconstruction | Breast RevisionUnited States
-
Sientra, Inc.TerminatedBreast Augmentation | Breast Revision-AugmentationUnited States
-
Arshad KhananiGenentech, Inc.CompletedNeovascular Age-Related Macular DegenerationUnited States
-
Arshad KhananiGenentech, Inc.CompletedDiabetic Macular EdemaUnited States
-
Cullinan Oncology Inc.RecruitingAdvanced Solid TumorUnited States
-
Kura Oncology, Inc.RecruitingNon Small Cell Lung Cancer (NSCLC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Colorectal Cancer (CRC) | Clear Cell Renal Cell Carcinoma (ccRCC) | Solid Tumors With HRAS AlterationsUnited States
-
Taiho Oncology, Inc.RecruitingAdvanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) MutationsUnited States, Japan, Spain, Italy, Korea, Republic of, Canada, France, Australia, Germany, United Kingdom, Hong Kong, Turkey
-
Taiho Oncology, Inc.RecruitingPancreatic Cancer | Esophageal Adenocarcinoma | Esophageal Squamous Cell Cancer | Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer | Siewert Type 1 GEJ CancerUnited States, Spain, Germany, France
-
Taiho Oncology, Inc.RecruitingNon-Small Cell Lung CancerUnited States, France, Italy, Korea, Republic of, Japan, Spain, Germany, Netherlands, United Kingdom
-
ALX Oncology Inc.RecruitingBladder Cancer | Urothelial CarcinomaUnited States
-
Kura Oncology, Inc.Recruiting
-
Taiho Oncology, Inc.RecruitingBreast Cancer | Glioblastoma | Solid Tumor | Non-small Cell Lung CancerUnited States, France
-
Mural Oncology, IncRecruitingAdvanced Solid TumorUnited States, Spain
-
CG Oncology, Inc.RecruitingNon Muscular Invasive Bladder CancerUnited States, Korea, Republic of, Taiwan, Japan, Australia
-
Kura Oncology, Inc.AvailableHRAS Mutations or Peripheral T Cell Lymphoma (PTCL)
-
Taiho Oncology, Inc.Approved for marketingAdvanced CholangiocarcinomaUnited States
-
Mural Oncology, IncCompletedAdvanced Solid TumorsCanada, Spain, United States, Australia, Belgium, Korea, Republic of, Poland
-
Rain Oncology IncTerminatedMelanoma | Sarcoma | Cervical Cancer | Testicular Germ Cell Tumor | Gastric Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Lung Adenocarcinoma | Solid Tumors | Pancreas Cancer | Head and Neck Carcinoma | Biliary Tract Cancer | Ovarian Carcinoma | Adrenocortical Carcinoma | Bladder Urothelial Carcinoma | Breast... and other conditionsUnited States
-
Rain Oncology IncTerminatedDedifferentiated LiposarcomaUnited States, Spain, France, Korea, Republic of, Taiwan, Canada, Hong Kong, Austria, Germany, Belgium, Georgia, Ireland, Italy, Poland, United Kingdom
-
Taiho Oncology, Inc.Active, not recruitingAdvanced or Metastatic Solid Tumor | Advanced or Metastatic Gastric or Gastroesophageal Cancer | Myeloid or Lymphoid Neoplasms (MLN)United States, Spain, Turkey, Hong Kong, Korea, Republic of, Belgium, Japan, Netherlands, France, Germany, Italy, Sweden, United Kingdom, Portugal, Singapore
-
Taiho Oncology, Inc.TerminatedAdvanced Solid Tumors With HER2 Abnormalities | Advanced Solid Tumors With HER3 AbnormalitiesUnited States, Spain, France, United Kingdom
-
Rain Oncology IncTerminatedNSCLC | Non-small Cell Lung Cancer | Non-squamous NSCLCUnited States, Australia
-
Rain Oncology IncTerminatedMetastatic Head-and-neck Squamous-cell CarcinomaUnited States, Australia
-
Taiho Oncology, Inc.Completed
-
Taiho Oncology, Inc.CompletedRefractory Metastatic Gastric CancerFrance, United States, Spain, United Kingdom, Germany, Ireland, Japan, Belgium, Italy, Turkey, Belarus, Israel, Portugal, Russian Federation, Czechia, Poland, Canada, Romania
-
Taiho Oncology, Inc.TerminatedMultiple Myeloma | NonHodgkin LymphomaUnited States
-
Kura Oncology, Inc.CompletedLeukemia, Myelomonocytic, ChronicUnited States
-
CG Oncology, Inc.CompletedSafety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure (BOND2)Bladder CancerUnited States
-
Clovis Oncology, Inc.TerminatedLocally Advanced or Metastatic Non Small Cell Lung CancerUnited States, Australia, France, Poland